Summit Therapeutics Inc.SMMTNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank86
3Y CAGR-16.5%
5Y CAGR+24.2%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-16.5%/yr
vs +46.9%/yr prior
5Y CAGR
+24.2%/yr
Recent deceleration
Acceleration
-63.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20259.87-2.8%
202410.15+9.2%
20239.30-45.1%
202216.93+345.9%
20213.80+13.7%
20203.34-46.8%
20196.27+72.8%
20183.63+91.7%
20171.89-38.1%
20163.06-